Search - tctmd.com

Displaying 61 - 80 of 926

Sort: Relevancy | Date

Patch May Prevail Where Prior Wearable Defibrillators Faltered: Jewel IDE Study

News Daily News

Patch May Prevail Where Prior Wearable Defibrillators Faltered: Jewel IDE Study

July 30, 2024

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

News Daily News

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Michael O'Riordan

July 29, 2024

Aortic Wall Thrombus in TAVI Patients Portends Thromboembolic Events

News Daily News

Aortic Wall Thrombus in TAVI Patients Portends Thromboembolic Events

July 23, 2024

CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI

News Daily News

CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI

Yael L. Maxwell

July 18, 2024

Lower-Dose Edoxaban May Be an Option After Age 80: ENGAGE AF-TIMI 48 Analysis

News Daily News

Lower-Dose Edoxaban May Be an Option After Age 80: ENGAGE AF-TIMI 48 Analysis

July 12, 2024

Ideal Aspirin Dose in Secondary Prevention Doesn’t Differ Much by Sex

News Daily News

Ideal Aspirin Dose in Secondary Prevention Doesn’t Differ Much by Sex

July 11, 2024

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

News Daily News

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Yael L. Maxwell

July 10, 2024

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

News Daily News

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Michael O'Riordan

July 01, 2024

Undiagnosed Valvular Heart Disease Prevalent in Older Adults

News Daily News

Undiagnosed Valvular Heart Disease Prevalent in Older Adults

Yael L. Maxwell

June 27, 2024

Semaglutide Has Similar Benefits in Women and Men With HFpEF

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

June 26, 2024

Aspirin for Primary Prevention of CVD Remains Common in US

News Daily News

Aspirin for Primary Prevention of CVD Remains Common in US

June 24, 2024

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

News Daily News

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

Michael O'Riordan

June 24, 2024

ApoB Can Be High, Risky for ASCVD Even When LDL’s Normal

News Daily News

ApoB Can Be High, Risky for ASCVD Even When LDL’s Normal

Yael L. Maxwell

June 17, 2024

Benefits of 12-Month DAPT After CABG Persist to 5 Years: DACAB

News Daily News

Benefits of 12-Month DAPT After CABG Persist to 5 Years: DACAB

Yael L. Maxwell

June 14, 2024

Remote Monitoring May Curb Recurring BP Problems of Pregnancy

News Daily News

Remote Monitoring May Curb Recurring BP Problems of Pregnancy

June 13, 2024

UK Physicians, Decrying Scope Creep, Ask Royal College President to Resign

News Daily News

UK Physicians, Decrying Scope Creep, Ask Royal College President to Resign

June 12, 2024

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

News Daily News

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

Michael O'Riordan

June 04, 2024

Patient Decision Aid Improves Shared Decision-making in Aortic Stenosis

News Daily News

Patient Decision Aid Improves Shared Decision-making in Aortic Stenosis

Yael L. Maxwell

May 28, 2024

FLOW: Semaglutide Scores Big in Diabetic Patients With CKD

News Daily News

FLOW: Semaglutide Scores Big in Diabetic Patients With CKD

May 24, 2024

Event Rates, Effect Sizes Often Overestimated in Major CV Trials

News Daily News

Event Rates, Effect Sizes Often Overestimated in Major CV Trials

May 09, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.